The Ministry of Health of the Russian Federation has registered the domestic medicinal product “Morphine, 20 mg/ml drops for oral administration" manufactured by FSUE Endopharm.
Marketing Authorization No. LP-008285.
The medicinal product belongs to the pharmacotherapeutic group of analgesic narcotic medicinal products and is included in List II of "List of Narcotic Drugs, Psychotropic Substances and Their Precursors Subject to Control in the Russian Federation".
The indication for the use of the medicinal product "Morphine, 20 mg/ml drops for oral administration" is an acute and chronic pain syndrome of severe intensity, not relieved by other medicinal products.
Recommended for use for medical reasons from 18 years of age.
The project has been implemented as part of the implementation of Action Plan (“road map”) “Increase of availability of narcotic drugs and psychotropic substances for medical use” approved by Decree No. 1403-r of the Government of the Russian Federation dated July 01, 2016.
In the period from 2016 to the present, FSUE Endopharm has developed, registered and put into production 12 new medicinal products used in the provision of palliative care according to 8 international non-proprietary names (INN) in 10 dosage forms.
The emergence of domestic non-invasive medicinal products with the INN of morphine led to a decrease in the share of their import from 100 % to 20 %*, and also made it possible to ensure the availability of medicinal products in 3 dosage forms not previously used in Russia for needy patients.
Comment type is not specified in the component properties.